Helsinn, a privately owned cancer supportive care pharmaceutical group has an extensive portfolio of marketed products and a broad development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients, guided by core family values of respect, integrity, quality, through a unique licensing business model and working with long standing partners in pharmaceuticals, medical devices and nutritional supplement products. Headquartered in Switzerland, Helsinn has operating subsidiaries in Ireland, US (direct sales & marketing) and a representative office in China.